Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is ...

BioLineRx Ltd. and Hemispherian AS announced they presented preclinical data at the 2026 European Society for Medical Oncology Annual Congress (ESMO 2026) demonstrating synergy between GLIX1 and ...

KIT researchers identified CD44 as a potential target for pancreatic cancer treatment by altering cancer-associated ...

Cancer research is a rapidly progressing field, and encompasses a range of disciplines, including basic and translational ...

Genialis Supermodel shows how biology-first AI can extract meaningful insights from limited patient data, across clinical ...

A saliva or cheek swab test could eventually help doctors prioritize patients for endoscopy, particularly in communities with ...

The activity of six different genes can help determine patient survival of acute myeloid leukemia (AML), according to a study ...

The metastatic outcome depends on the state of disseminated cancer cells (DCCs) leading to overt metastasis or undergoing ...

UCLA investigators have developed a new artificial intelligence-based platform that could help scientists identify promising ...

In this GEN webinar, our expert speaker Josh Wheeler, MD, PhD, will discuss a biology-first, interpretable AI approach to ...